All News

The USA Drug pharmacy chain and its stores are now officially owned by Walgreens.

Some consumers have reported burning pain and blistering following the use of OTC topical pain relievers, FDA reported recently.

Retail pharmacies’ smoking cessation programs are effective in helping smokers quit, according to a study published in the September issue of The Annals of Pharmacotherapy.

What’s different in your drug stores this month or coming very soon? Chewable omega-3 jellies for kids. An oral antiseptic spray. A more-tapered cotton swab. Tasty vitamins that melt in the mouth. Shoes and sandals with arch supports. A non-habit-forming sleep aid. And there are even more new over-the-counter items featured in the print edition of Drug Topics.

Health Mart has appointed Stephen E. Courtman as its new president, the pharmacy franchiser announced today in a press release.

Walgreens is rolling out a new program to reward its customers with cost savings, points, and rewards for purchases, services, and healthy behaviors.

Professions survive and prosper when mentors and their juniors embrace one another respectfully and cooperatively for the progressive promotion of their vocation. In this way, the seniors would not carry their valuable professional experience to their graves, and the juniors would not commit irreparable blunders as they enter the stage of practice.

Suppose a country were facing a flood of Biblical proportions but determined to focus on bringing in more tourism; what would you say about its priorities? Now suppose that country were a professional organization and ... well, read on.

Walmart has launched its own ReliOn brand diabetes products.

Great ideas are everywhere. Successful community pharmacists can spot them and tailor them to meet local needs. Here are four stories of how good ideas gave rise to even better ones.

If the Washington, D.C.-based Patient-Centered Primary Care Collaborative has anything to say about it, MTM will help shift pharmacists' roles from dispensing to direct clinical practice.

Healthcare delivery in the United States has evolved as more patients visit their neighborhood retail clinics for acute and preventive care.

While the Risk Evaluation and Mitigation Strategies program has come under fire for its inefficiencies, all is not yet lost.

Patients suffering stroke often do not seek immediate help. Just as disturbing, lack of stroke expertise in many hospitals and skepticism among ER physicians may prevent tPA from being administered to the patients who need it most.

FDA approves Lorcaserin and Mirabegron extended-release tablets.

Ticagrelor is shown to be better at platelet inhibition. Warfarin seen as beneficial to patients with PAH. Dabigatran's problems aren't over.

Findings at the International AIDS Conference support the need to start antiretroviral therapy as soon as possible after diagnosis.

A round-up of OTC products to help manage dandruff and head lice.

A survey of new Rx, new generic, and new OTC products

Despite growing consumer education, children and teenagers are increasingly abusing prescription drugs. Two manufacturers have recently launched products designed to keep Rx drugs secure in the home.

The Specialty Pharmacy Certification Board has developed a Certified Specialty Pharmacist credential, which it hopes to launch in early 2013.

Medication errors can't be completely eliminated, but can CQI programs keep them to a minimum?

An encounter with a police officer reminds JP that the world sees pharmacists only as pill counters.

Federal agencies have fined an LTC provider $50 million for improperly dispensing controlled substances.

Mandatory mail-order programs are hampering medication adherence, said Marie Smith, PharmD, during a recent roundtable on medication adherence.

The ways of PBMs are convoluted and mysterious. If we don't keep a sharp eye out, one of these days we'll be getting prescriptions out of vending machines.

Readers have their say on unionization, fair reimbursement, and self-regulation.

FDA has approved teriflunomide (Aubagio, Genzyme, a Sanofi company), a once-daily, oral treatment indicated for patients with relapsing forms of multiple sclerosis.